Latest News

Q1 2026 earnings snapshot and how it fits the Green Thumb story Green Thumb Industries (CNSX:GTII) opened 2026 with Q1 revenue of US$300.2 million and basic EPS of US$0.07, alongside trailing 12 month EPS of US$0.52 on revenue of about US$1.2 billion. Over the past year, the company has seen revenue move from US$1.14 billion to US$1.20 billion on a trailing basis, while trailing net income shifted from US$73.1 million to US$121.2 million, supporting that 141% earnings growth figure that has...

Ascopiave (BIT:ASC) opened 2026 with Q1 revenue of €70.8 million and basic EPS of €0.034, against a backdrop of trailing twelve month revenue of €260.3 million and EPS of €0.391. Over the past year, the company has seen revenue move from €204.9 million to €260.3 million and EPS from €0.165 to €0.391, alongside trailing net income rising from €35.8 million to €85.0 million and net margin shifting from 18.2% to 32.7%. This sets up a results season in which richer margins are front and center...

Curtiss-Wright (CW) opened 2026 with Q1 revenue of US$913.7 million and Basic EPS of US$3.47, while trailing twelve month revenue sat at about US$3.6 billion with EPS of US$13.73 and net income of US$511.1 million. Over the last five reported quarters, revenue has moved from US$805.6 million in Q1 2025 to US$913.7 million in Q1 2026, with Basic EPS over that span ranging between US$2.69 and US$3.71. With trailing net profit margin edging higher over the past year, these results give investors...

First quarter earnings event and why it matters for the stock China Communications Construction (SEHK:1800) has put fresh numbers in front of investors, reporting first quarter 2026 earnings that show revenue near CNY 155.9b and lower profitability compared with the same period last year. See our latest analysis for China Communications Construction. The stock has been under pressure over the past few months, with a 90 day share price return of 10.83% and a year to date share price return of...

Primerica (PRI) opened 2026 with Q1 revenue of US$885.9 million and basic EPS of US$6.00, supported by net income of US$190.1 million and a combined ratio of 65.2%, setting a clear tone for how the year is starting. The company has seen quarterly revenue move from US$803.4 million in Q4 2024 to US$819.5 million in Q1 2025 and then to US$885.9 million in Q1 2026. Over that period, basic EPS ranged from US$4.99 to US$6.36, pointing to a business that is still generating meaningful profits as...

EDP Renewables (ENXTLS:EDPR) opened Q1 2026 with revenue of €739 million and net income of €70 million, translating into basic EPS of €0.07, as investors weigh these figures against a current share price of €13.96. The company reported quarterly revenue of €649 million in Q1 2025 and €739 million in Q1 2026, while net income moved from €52 million to €70 million over the same period, alongside trailing twelve month EPS of €0.22 on €2.2 billion of revenue. For investors, a key consideration is...

Henkel KGaA (XTRA:HEN3) is back in focus after reporting 1.7% organic sales growth for Q1 2026, completing a €1b share buyback, and advancing acquisitions that are expected to add around €1.6b in annual sales. See our latest analysis for Henkel KGaA. At a share price of €64.58, Henkel’s stock has seen a 3.99% 7 day share price return but a 19.05% 90 day share price decline, with a 5 year total shareholder return of 22.06% decline, which may indicate fading momentum despite the recent Q1...

Century Aluminum (CENX) has released its first quarter 2026 earnings, reporting revenue of US$649.2 million and net income of US$337.5 million, figures that sharply contrast with the prior year’s results. See our latest analysis for Century Aluminum. The stock has been active around the earnings release, with a 1-day share price return of a 3.26% decline, a 90-day share price return of 15.61% and a very large 1-year total shareholder return, suggesting momentum has been building over a longer...

In the first quarter of 2026, Clear Secure, Inc. reported revenue of US$253 million and net income of US$38.8 million, and also affirmed a quarterly dividend of US$0.15 per share payable on June 24, 2026. The company paired these record results with second-quarter 2026 revenue guidance of US$268 million–US$271 million and higher free cash flow expectations, highlighting growing traction for products like eGates and Concierge as it targets wider identity and GovTech opportunities. We’ll now...

If you are wondering whether Franklin Resources stock still offers value at current levels, it helps to start with how the market has been treating it recently and what that might imply about expectations. The stock last closed at US$30.52, with returns of 1.8% over 7 days, 28.3% over 30 days, 28.2% year to date, and 54.8% over 1 year. This puts recent price action firmly on investors' radar. Recent news coverage has focused on Franklin Resources' position as a global asset manager and its...

Why Huntsman Stock Is Back In Focus After Recent Company Updates Huntsman (HUN) has drawn fresh attention after management highlighted recent price increases, efforts to offset higher costs, and comments on demand trends and margins heading into the second quarter. See our latest analysis for Huntsman. Recent company updates on pricing, demand and margins have come alongside a 44.65% year to date share price return, while the 1 year total shareholder return of 30.18% contrasts with a weaker 3...

ResMed (RMD) recently combined a CFO transition with quarterly results that showed higher sales, net income and earnings per share year over year, a mix that tends to sharpen investor focus on the stock. See our latest analysis for ResMed. Even with higher quarterly sales and earnings, ResMed’s recent share price has been under pressure, with a 30 day share price return of an 8.48% decline and a 90 day share price return of a 23.83% decline. The 1 year total shareholder return of a 14.31%...

In the past quarter, NOV Inc. repurchased 3,500,000 shares for US$67 million, completing a broader buyback of 40,475,436 shares for US$611.23 million under its April 26, 2024 authorization, while reporting first-quarter 2026 revenue of US$2,052 million and net income of US$19 million, both lower than a year earlier. The earnings release, guidance for a 4% to 6% year-over-year revenue decline in the second quarter of 2026, and Barclays’ downgrade to Underweight despite a more positive view on...

Mueller Water Products (NYSE:MWA) has flagged a higher priority on acquisitions, with management highlighting more active work on potential targets. The company is planning to use its balance sheet and increased M&A readiness to expand its portfolio and support net sales growth. This marks a shift in capital allocation focus toward deals that could reshape its market presence and operating profile. Mueller Water Products focuses on water infrastructure products and services, an area that...

Chubb (NYSE:CB) has formed an alliance with Verified Clinical Trials to support risk management and data quality in clinical research. The partnership focuses on research subject safety, data integrity, and reducing operational and regulatory risks using VCT's subject registry technology. This development extends Chubb's activity beyond traditional insurance coverage into technology driven clinical trial risk solutions. For investors tracking Chubb at a current share price of $321.28, the...

Oma Säästöpankki Oyj (HLSE:OMASP) opened 2026 with Q1 revenue of €43.2 million and basic EPS of €0.33, set against trailing 12 month revenue of €175.5 million and EPS of €1.46. Over the last year, revenue has moved from €167.0 million to €175.5 million and EPS from €1.27 to €1.46, with net income over the same period shifting from €42.1 million to €48.1 million. The latest quarter therefore follows a period of expanding earnings power and firmer margins that investors will be watching...

Why Biogen (BIIB) is on investors’ radar today Biogen (BIIB) has drawn fresh attention after recent share price moves, with the stock up about 9% over the past month but showing a roughly 5% decline over the past 3 months. See our latest analysis for Biogen. The recent 8.98% 1 month share price return, alongside a 7.63% year to date share price return and 61.65% 1 year total shareholder return, suggests momentum has picked up again after weaker 3 year and 5 year total shareholder returns. If...

Why Buckle Stock Is Back On Investors’ Radar Buckle (BKE) is attracting fresh attention after a period of mixed short term returns, with the stock showing a small gain over the past month and a modest rise over the past 3 months. See our latest analysis for Buckle. Short term share price momentum has cooled, with a 1 day share price return decline of 4.01% and a 7 day share price return decline of 5.84%, while the 1 year total shareholder return of 53.77% still points to a strong longer term...

If you are wondering whether Constellation Energy stock is trading at an attractive price or starting to look stretched, the key is understanding what the current valuation is really telling you. The stock last closed at US$311.28, with returns of 14.2% over the past 30 days and 15.6% over the last year, set against a 15.0% decline year to date and a very large gain over three years. Recent headlines around Constellation Energy have focused on its position within the utilities sector and...

In early May 2026, TowneBank was caught up in a broader regional bank pullback as renewed U.S.-Iran tensions drove oil prices higher and pushed Treasury yields toward nine-month highs, rekindling stagflation worries. This episode highlights how quickly the macro backdrop, especially inflation-driven moves in the yield curve, can alter perceptions of earnings resilience for regional lenders like TowneBank. We’ll now examine how this inflation-driven shift in Treasury yields may influence...

If you are wondering whether Entergy stock still offers value at recent prices, it helps to step back and look at both the recent returns and what they might be pricing in. The stock last closed at US$112.02, with a 7 day return of a 5% decline, a 30 day return of a 1.6% decline, and a gain of 19.3% year to date and 37.9% over the past year, with multi year returns that have been very large over 3 and 5 years. Recent price moves sit against a backdrop of ongoing interest in regulated...

If you are wondering whether ASICS stock still offers value after its strong run, or if you might be late to the story, this article breaks down what the current price could be implying. The stock last closed at ¥4,640, with returns of 6.9% over 7 days, 4.7% over 30 days, 20.6% year to date and 40.7% over 1 year, while the 3 year return is very large and the 5 year return is close to 8x. Recent coverage has focused on ASICS as a long term compounder in the athletic footwear space. Attention...

Why Independent Bank's new buyback is drawing attention Independent Bank (INDB) has put a fresh US$200 million share repurchase program on the table, running through April 2027, which immediately puts capital returns and valuation front and center for investors. See our latest analysis for Independent Bank. Independent Bank's share price has softened recently, with a 9.05% 90 day share price return, yet the 1 year total shareholder return of 30.63% and 3 year total shareholder return of...

In the first quarter of 2026, Zevra Therapeutics reported sales of US$36.22 million, net income of US$37.89 million, and a swing to positive earnings per share, supported by a US$43.3 million gain from selling its SDX portfolio and retiring US$63.1 million of term debt. At the same time, Zevra sharpened its rare disease focus with early MyPlifer traction in Niemann-Pick disease type C, progress on celiprolol for vascular Ehlers-Danlos syndrome, and a strong cash position of US$236.8 million,...